financetom
Business
financetom
/
Business
/
Regeneron Pharmaceuticals Q2 Adjusted Earnings, Revenue Rise; Shares Up
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Regeneron Pharmaceuticals Q2 Adjusted Earnings, Revenue Rise; Shares Up
Aug 1, 2025 4:17 AM

06:53 AM EDT, 08/01/2025 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) reported Q2 adjusted earnings Friday of $12.89 per diluted share, up from $11.56 a year earlier.

Analysts surveyed by FactSet expected $8.43.

Revenue for the quarter ended June 30 was $3.68 billion, compared with $3.55 billion a year earlier.

Analysts polled by FactSet expected $3.29 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mgm Resorts Insider Sold Shares Worth $5,633,292, According to a Recent SEC Filing
Mgm Resorts Insider Sold Shares Worth $5,633,292, According to a Recent SEC Filing
Jun 14, 2024
05:16 PM EDT, 06/14/2024 (MT Newswires) -- Keith A. Meister, Director, on June 13, 2024, sold 139,300 shares in Mgm Resorts ( MGM ) for $5,633,292. Following the Form 4 filing with the SEC, Meister has control over a total of 5,859,478 shares of the company, with 5,859,478 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/789570/000095017024073797/xslF345X03/ownership.xml Price: 39.78, Change: -0.07, Percent Change: -0.18...
Golub Capital Bdc 4 Insider Bought Shares Worth $4,500,473, According to a Recent SEC Filing
Golub Capital Bdc 4 Insider Bought Shares Worth $4,500,473, According to a Recent SEC Filing
Jun 14, 2024
05:11 PM EDT, 06/14/2024 (MT Newswires) -- Lawrence E Golub, 10% Owner, Director, Chairman, on June 13, 2024, executed a purchase for 300,032 shares in Golub Capital Bdc 4 (NONE) for $4,500,473. Following the Form 4 filing with the SEC, Golub has control over a total of 4,573,671 shares of the company, with 4,573,671 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1901612/000190161224000051/xslF345X03/wk-form4_1718399346.xml ...
BRIEF-S.H.N. Financial Investments Ltd. Reports 9.99% Passive Stake In Endra Life Sciences Inc As Of June 4, 2024- SEC Filing
BRIEF-S.H.N. Financial Investments Ltd. Reports 9.99% Passive Stake In Endra Life Sciences Inc As Of June 4, 2024- SEC Filing
Jun 14, 2024
ENDRA Life Sciences Inc ( NDRA ): * S.H.N. FINANCIAL INVESTMENTS LTD. REPORTS 9.99% PASSIVE STAKE IN ENDRA LIFE SCIENCES INC AS OF JUNE 4, 2024- SEC FILING Source text for Eikon: Further company coverage: ...
BRIEF-Winvest Acquisition Corp. Announces Extension Of Termination Date And Additional Contribution To Trust Account To Extend Termination Date
BRIEF-Winvest Acquisition Corp. Announces Extension Of Termination Date And Additional Contribution To Trust Account To Extend Termination Date
Jun 14, 2024
WinVest Acquisition Corp ( WINV ): * WINVEST ACQUISITION CORP. ( WINV ) ANNOUNCES EXTENSION OF TERMINATION DATE AND ADDITIONAL CONTRIBUTION TO TRUST ACCOUNT TO EXTEND TERMINATION DATE * WINVEST ACQUISITION CORP ( WINV ) - EXTEND DATE BY WHICH COMPANY MUST CONSUMMATE AN INITIAL BUSINESS COMBINATION FROM JUNE 17, 2024 TO JULY 17, 2024 Source text for Eikon: Further...
Copyright 2023-2026 - www.financetom.com All Rights Reserved